Overview of treatment plan quality in a high dose rate prostate brachytherapy workflow

被引:0
|
作者
Panetta, J. V. [1 ]
Veltchev, I. [1 ]
Horwitz, E. [1 ]
Hallman, M. [1 ]
Wong, K. [1 ]
Price, R. A. [1 ]
Ma, C. M. C. [1 ]
机构
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA
关键词
modality combinations: Varian Varisource/US; Elekta microSelectron/CT; ULTRASOUND; MONOTHERAPY; CANCER; CT; DOSIMETRY; PROGRAM;
D O I
10.1016/j.brachy.2024.08.255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: High dose rate brachytherapy (HDR-BT) has been shown to be an effective treatment for prostate cancer, with treatment plan quality dependent on a number of factors. In this work, we report on the overall performance of our ultrasound (US)-based workflow and the impact of several treatment-specific variables. METHODS AND MATERIALS: Patients who underwent HDR-BT (boost, monotherapy, and retreatment) using Varian Bravos/US from 2021 to 2023 were sampled for this study. Treatment plan quality was analyzed and plans were categorized with regard to a number of metrics, including: prostate volume, treating physician, planning physicist, number of needles included, estimated planning time, rectum-prostate separation, and bladder-prostate separation. The performance of this program was compared to the performance of our program using previously used RESULTS: Plan quality for our Bravos/US workflow was shown to be consistently above acceptability criteria for all personnel involved; on average: prostate V100%: 98.9% f 0.1%, rectum V75%: 0.04 f 0.01 cc, bladder V75%: 0.06 f 0.01cc, urethra V125%: 0.00 f 0.00 cc. Prostate coverage was statistically improved with this workflow compared to that using our previous modalities. There was a statistical correlation between organ-at-risk sparing/prostate coverage ratio and prostate volume, number of needles/prostate volume, bladder-prostate separation, and rectum-prostate separation. There was no correlation between plan quality and planning time. CONCLUSIONS: Our US-based HDR-BT program led to target coverage and organ-at-risk sparing that exceeded department thresholds. Results were acceptable regardless of the personnel involved and improved plan quality was obtained using more needles/prostate volume and increased spacing between the prostate and the rectum and bladder. (c) 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:698 / 704
页数:7
相关论文
共 50 条
  • [41] An Analysis of Learning Curve Effect on the Speed and Quality of High Dose Rate Prostate Brachytherapy Procedures
    Coupal, D.
    Amjad, A.
    Sadikov, E.
    Fay, A.
    Glass, L.
    Hordos, J.
    Liu, D.
    Lukowich, K.
    Marchant, K.
    McKenzie, J.
    McVicar, L.
    Otitoju, C.
    Penna, S.
    Shaw, J.
    Thakur-Singh, V.
    Smith, A.
    Tremblay, C.
    Leong, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E885 - E885
  • [42] High dose rate prostate brachytherapy causes minimal acute toxicity and maintains quality of life
    Gejerman, G
    Mullokandov, EA
    Lev, E
    Saini, AJ
    Rebo, I
    Vikram, B
    CANCER JOURNAL, 2001, 7 (06): : 546 - 546
  • [43] Does inverse planning improve plan quality in interstitial high-dose-rate breast brachytherapy?
    Major, Tibor
    Frohlich, Georgina
    Meszaros, Norbert
    Smanyko, Viktor
    Polgar, Csaba
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (02) : 166 - 174
  • [44] Quality of life after high-dose rate brachytherapy monotherapy for prostate cancer.
    Contreras, Jessika
    Wilder, Richard
    Mellon, Eric Albert
    Strom, Tobin Joel Crill
    Fernandez, Daniel Celestino
    Biagioli, Matthew C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [45] Low dose rate prostate brachytherapy
    Stish, Bradley J.
    Davis, Brian J.
    Mynderse, Lance A.
    McLaren, Robert H.
    Deufel, Christopher L.
    Choo, Richard
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 341 - 356
  • [46] Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer
    Murgic, Jure
    Chung, Peter
    Berlin, Alejandro
    Bayley, Andrew
    Warde, Padraig
    Catton, Charles
    Simeonov, Anna
    Abed, Jessamine
    O'Leary, Gerald
    Rink, Alexandra
    Menard, Cynthia
    BRACHYTHERAPY, 2016, 15 (02) : 147 - 155
  • [47] Interfractional fluctuation of rectal dose in high dose rate brachytherapy for prostate cancer
    Ishikawa H.
    Sato M.
    Shirai S.
    Kishi K.
    Naya Y.
    Tokunaga H.
    Radiation Medicine, 2006, 24 (9): : 610 - 616
  • [48] High dose rate transurethral brachytherapy as a boost dose for localized adenocarcinoma of the prostate
    Serin, M
    Erkal, HS
    Sak, SD
    Cakmak, A
    Gogus, O
    Akkaya, A
    UROLOGIA INTERNATIONALIS, 1997, 58 (01) : 30 - 33
  • [49] Prostate segmentation accuracy using synthetic MRI for high-dose-rate prostate brachytherapy treatment planning
    Kang, Hyejoo
    Podgorsak, Alexander R.
    Venkatesulu, Bhanu Prasad
    Saripalli, Anjali L.
    Chou, Brian
    Solanki, Abhishek A.
    Harkenrider, Matthew
    Shea, Steven
    Roeske, John C.
    Abuhamad, Mohammed
    PHYSICS IN MEDICINE AND BIOLOGY, 2023, 68 (15):
  • [50] American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy
    Yamada, Yoshiya
    Rogers, Leland
    Demanes, D. Jeffrey
    Morton, Gerard
    Prestidges, Bradley R.
    Pouliot, Jean
    Cohen, Gil'ad N.
    Zaider, Marco
    Ghilezan, Mihai
    Hsu, I-Chow
    BRACHYTHERAPY, 2012, 11 (01) : 20 - 32